Development of a potent class of small molecule inhibitors of the MDM2-p53 protein-protein interaction

被引：1

作者：

Fazal, Lynsey ^{[1
]}

Ahn, Maria ^{[1
]}

Bevan, Luke ^{[1
]}

Buck, Ildiko ^{[1
]}

Castro, Juan ^{[1
]}

Chessari, Gianni ^{[1
]}

Cons, Ben ^{[1
]}

Hearn, Keisha ^{[1
]}

Howard, Steven ^{[1
]}

Johnson, Chris ^{[1
]}

Reeks, Judith ^{[1
]}

Tamanini, Emiliano ^{[1
]}

Thompson, Neil ^{[1
]}

Walton, Hugh ^{[1
]}

Williams, Pamela ^{[1
]}

Bawn, Ruth H. ^{[2
]}

Blackburn, Tim J. ^{[2
]}

Cano, Celine ^{[2
]}

Cully, Sarah J. ^{[2
]}

Golding, Bernard ^{[2
]}

Griffin, Roger ^{[2
]}

Haggerty, Karen ^{[2
]}

Hardcastle, Ian ^{[2
]}

Newell, Herbie ^{[2
]}

Noble, Martin ^{[2
]}

Thomas, Huw ^{[2
]}

Willmore, Elaine ^{[2
]}

Zhao, Yan ^{[2
]}

Wedge, Steve ^{[2
]}

机构：

[1] Astex Therapeut, Cambridge, England

[2] Nothern Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England

来源：

CANCER RESEARCH | 2018年 / 78卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2018-1652

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1652

引用

页数：3

共 50 条

[41] Identification of a disruptor of the MDM2-p53 protein-protein interaction facilitated by high-throughput in silico docking
Lawrence, Harshani R.
Li, Zhenyu
Yip, M. L. Richard
Sung, Shen-Shu
Lawrence, Nicholas J.
McLaughlin, Mark L.
McManus, Gregory J.
Zaworotko, Michael J.
Sebti, Said M.
Chen, Jiandong
Guida, Wayne C.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (14) : 3756 - 3759
[42] Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models
Bowman, Anna L.
Nikolovska-Coleska, Zaneta
Zhong, Haizhen
Wang, Shaomeng
Carlson, Heather A.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (42) : 12809 - 12814
[43] Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models
Bowman, Anna L.
Nikolovska-Coleska, Zaneta
Zhong, Haizhen
Wang, Shaomeng
Carlson, Heather A.
Journal of the American Chemical Society, 2007, 129 (42): : 12809 - 12814
[44] Inhibitors of the MDM2-p53 interaction as anticancer drugs
Hardcastle, Ian R.
DRUGS OF THE FUTURE, 2007, 32 (10) : 883 - 896
[45] Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction
Ding, Ke
Lu, Yipin
Nikolovska-Coleska, Zaneta
Wang, Guoping
Qiu, Su
Shangary, Sanjeev
Gao, Wei
Qin, Dongguang
Stuckey, Jeanne
Krajewski, Krzysztof
Roller, Peter P.
Wang, Shaomeng
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (12) : 3432 - 3435
[46] The MDM2-p53 interaction
Moll, UM
Petrenko, O
MOLECULAR CANCER RESEARCH, 2003, 1 (14) : 1001 - 1008
[47] Discovery of Potent and Simplified Piperidinone-Based Inhibitors of the MDM2-p53 Interaction
Yu, Ming
Wang, Yingcai
Zhu, Jiang
Bartberger, Michael D.
Canon, Jude
Chen, Ada
Chow, David
Eksterowicz, John
Fox, Brian
Fu, Jiasheng
Gribble, Michael
Huang, Xin
Li, Zhihong
Liu, Jiwen
Lo, Mei-chu
McMinn, Dustin
Oliner, Jonathan D.
Osgood, Tao
Rew, Yosup
Saiki, Anne Y.
Shaffer, Paul
Yan, Xuelei
Ye, Qiuping
Yu, Dongyin
Zhao, Xiaoning
Zhou, Jing
Olson, Steven H.
Medina, Julio C.
Sun, Daqing
ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (08): : 894 - 899
[48] Design and synthesis of non-peptidic a-helix mimics targeting for MDM2-p53 protein-protein interaction
Zhou, Mingzhou
Topper, Melissa E.
Anderson, Laura
McLaughlin, Jillian M.
Santiago, Daniel N.
Fronczek, Frank R.
Guida, Wayne C.
McLaughlin, Mark L.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
[49] Small molecule inhibitors of the XIAP protein-protein interaction
Rajapakse, Hemaka A.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (10) : 966 - 971
[50] Insight on Heterocycles as p53-MDM2 Protein-Protein Interaction Inhibitors: Molecular Mechanism for p53 Activation
Basha, N. Jeelan
Mohan, R. M.
CHEMISTRYSELECT, 2024, 9 (10):

← 1 2 3 4 5 →